PHRRF (PharmaTher Holdings) ROCE %: -160.62% (As of Feb. 2026)


What is PharmaTher Holdings ROCE %?

PharmaTher Holdings PHRRF +4.74% ROCE % is -160.62% as of Feb. 2026. The stock has 2 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. PharmaTher Holdings's annualized ROCE % for the quarter that ended in Feb. 2026 was -160.62%.

PharmaTher Holdings  (OTCPK:PHRRF) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

PharmaTher Holdings ROCE % Related Terms

PharmaTher Holdings ROCE % Historical Data

* Premium members only.

The historical data trend for PharmaTher Holdings's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PharmaTher Holdings ROCE % Chart

PharmaTher Holdings Annual Data
Trend May21 May22 May23 May24 May25
ROCE %
-48.83 -45.70 -44.96 -79.01 -93.78

PharmaTher Holdings Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -100.50 -199.10 -153.07 -126.45 -160.62

PharmaTher Holdings ROCE % Calculation

PharmaTher Holdings's annualized ROCE % for the fiscal year that ended in May. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: May. 2025 )  (A: May. 2024 )(A: May. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: May. 2025 )  (A: May. 2024 )(A: May. 2025 )
=-1.131/( ( (1.895 - 0.185) + (0.966 - 0.264) )/ 2 )
=-1.131/( (1.71+0.702)/ 2 )
=-1.131/1.206
=-93.78 %

PharmaTher Holdings's ROCE % of for the quarter that ended in Feb. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Feb. 2026 )  (Q: Nov. 2025 )(Q: Feb. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Feb. 2026 )  (Q: Nov. 2025 )(Q: Feb. 2026 )
=-0.62/( ( (0.697 - 0.316) + (0.779 - 0.388) )/ 2 )
=-0.62/( ( 0.381 + 0.391 )/ 2 )
=-0.62/0.386
=-160.62 %

(1) Note: The EBIT data used here is four times the quarterly (Feb. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -160.62% mean?
PharmaTher Holdings (PHRRF) has a ROCE % of -160.62% as of Feb. 2026.
Is PharmaTher Holdings' ROCE % too high?
PharmaTher Holdings' current ROCE % is -160.62%.
How does PharmaTher Holdings' ROCE % compare to VRTX and REGN?
PharmaTher Holdings' ROCE % of -160.62% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Biotechnology company?
A good ROCE % depends on the Biotechnology industry context. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. PharmaTher Holdings's current ROCE % is -160.62%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PharmaTher Holdings stock overvalued right now?
PharmaTher Holdings (PHRRF) has a current ROCE % of -160.62%. The current ROCE % is -160.62%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For PharmaTher Holdings (PHRRF), the current ROCE % is -160.62% as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PharmaTher Holdings Business Description

Other Exchanges NCC0:GermanyPHRM:Canada
Address 82 Richmond Street East, Toronto, ON, CAN, M5C 1P1
PharmaTher Holdings Ltd is a specialty life sciences company focused on the research and development of psychedelic pharmaceuticals for FDA approval to treat mental health, neurological, and pain disorders. Its product pipeline includes Ketamine, KETABET, Microneedle Patch and others.